17-alpha-hydroxyprogesterone has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adlercreutz, H; Hautanen, A; Räikkönen, K | 1 |
| Auzeby, A; Bogdan, A; Heshmati, HM; Nahoul, K; Roger, M; Touitou, Y; Turpin, G; Varsaux, J | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Hyperlipemia
| Article | Year |
|---|---|
Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males.
Topics: 17-alpha-Hydroxyprogesterone; Abdomen; Adrenal Cortex; Adult; Body Constitution; Body Mass Index; C-Peptide; Cholesterol, HDL; Dehydroepiandrosterone; Glucose Tolerance Test; Humans; Hydrocortisone; Hyperinsulinism; Hyperlipidemias; Insulin; Life Style; Male; Middle Aged; Obesity; Pituitary-Adrenal System; Prospective Studies; Risk Factors; Triglycerides | 1997 |
Lack of effect in vivo of clofibrate on adrenal steroid secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Clofibrate; Humans; Hydroxyprogesterones; Hyperlipidemias; Male; Middle Aged; Progesterone | 1989 |